These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23266709)

  • 1. Selfish brain and neuroprogression in bipolar disorder.
    Mansur RB; Cha DS; Asevedo E; McIntyre RS; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():66-71. PubMed ID: 23266709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
    Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
    Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The "selfish brain" hypothesis for metabolic abnormalities in bipolar disorder and schizophrenia.
    Mansur RB; Brietzke E
    Trends Psychiatry Psychother; 2012 Sep; 34(3):121-8. PubMed ID: 25923003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder.
    Walz JC; Andreazza AC; Frey BN; Cacilhas AA; Ceresér KM; Cunha AB; Weyne F; Stertz L; Santin A; Gonçalves CA; Kapczinski F
    Neurosci Lett; 2007 Mar; 415(1):87-9. PubMed ID: 17234344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance findings in bipolar disorder.
    Brambilla P; Glahn DC; Balestrieri M; Soares JC
    Psychiatr Clin North Am; 2005 Jun; 28(2):443-67. PubMed ID: 15826742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain metabolic alterations in medication-free patients with bipolar disorder.
    Dager SR; Friedman SD; Parow A; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
    Arch Gen Psychiatry; 2004 May; 61(5):450-8. PubMed ID: 15123489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?
    Soczynska JK; Kennedy SH; Goldstein BI; Lachowski A; Woldeyohannes HO; McIntyre RS
    Neurotoxicology; 2009 Jul; 30(4):497-521. PubMed ID: 19477018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder.
    Kapczinski F; Frey BN; Kauer-Sant'Anna M; Grassi-Oliveira R
    Expert Rev Neurother; 2008 Jul; 8(7):1101-13. PubMed ID: 18590480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Areas of controversy in neuroprogression in bipolar disorder.
    Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F
    Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
    Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J
    Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selfish brain: competition for energy resources.
    Peters A; Schweiger U; Pellerin L; Hubold C; Oltmanns KM; Conrad M; Schultes B; Born J; Fehm HL
    Neurosci Biobehav Rev; 2004 Apr; 28(2):143-80. PubMed ID: 15172762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptor blockers for bipolar disorder.
    de Góis Queiroz AI; Medeiros CD; Ribeiro BM; de Lucena DF; Macêdo DS
    Med Hypotheses; 2013 Mar; 80(3):259-63. PubMed ID: 23265360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.
    Calkin CV
    Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction for the allostatic load special issue.
    Peters A; McEwen BS
    Physiol Behav; 2012 Apr; 106(1):1-4. PubMed ID: 22226993
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel biomarkers for bipolar disorder.
    Teixeira AL; Barbosa IG; Machado-Vieira R; Rizzo LB; Wieck A; Bauer ME
    Expert Opin Med Diagn; 2013 Mar; 7(2):147-59. PubMed ID: 23530885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selfish brain and selfish immune system interplay: A theoretical framework for metabolic comorbidities of mood disorders.
    Yamagata AS; Mansur RB; Rizzo LB; Rosenstock T; McIntyre RS; Brietzke E
    Neurosci Biobehav Rev; 2017 Jan; 72():43-49. PubMed ID: 27871787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
    Soares JC; Krishnan KR; Keshavan MS
    Depression; 1996; 4(1):14-30. PubMed ID: 9160650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder.
    Bauer IE; Soares JC; Selek S; Meyer TD
    Mod Trends Pharmacopsychiatry; 2017; 31():10-26. PubMed ID: 28738324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic use of omega-3 fatty acids in bipolar disorder.
    Balanzá-Martínez V; Fries GR; Colpo GD; Silveira PP; Portella AK; Tabarés-Seisdedos R; Kapczinski F
    Expert Rev Neurother; 2011 Jul; 11(7):1029-47. PubMed ID: 21721919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical underpinnings in bipolar disorder and epilepsy.
    Amann B; Grunze H
    Epilepsia; 2005; 46 Suppl 4():26-30. PubMed ID: 15938708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.